Get the latest news, insights, and market updates on all tickers. Explore the news page 47 on MyTopStock.com for investor discussions, analysis, and real-time stock performance coverage.
TREMFYA® (guselkumab) long-term data show sustained clinical and endoscopic remission in ulcerative colitis through 3 years
Johnson & Johnson (NYSE: JNJ) today announced new long-term data from the QUASAR long-term extension (LTE) study showing that TREMFYA® (guselkumab) sustained clinical, endoscopic, and histologic outcomes through Week 140 in adults with moderately to severely active ulcerative colitis (UC). These data are among the 30 company-sponsored abstracts being presented at the European Crohn's and Colitis Organisation (ECCO) 2026 conference. Feb 21, 2026 - $JNJ
JPMorgan closed Trump accounts after Jan. 6 attack
Investing.com -- JPMorgan Chase & Co (NYSE:JPM) informed President Donald Trump and his hospitality business in February 2021 that it would close their bank accounts, according to newly disclosed letters included in court filings tied to Trump’s $5 billion lawsuit against the bank and its CEO Jamie Dimon. Feb 21, 2026 - $JPM
JPMorgan concedes it closed Trump's accounts after Jan. 6 attack
JPMorgan Chase acknowledged for the first time that it closed the bank accounts of President Donald Trump and several of his businesses in the political and legal aftermath of the Jan. 6, 2021 attacks on the U.S. Capitol, the latest development in a legal saga between the president and the nation's biggest bank over the issue known as “debanking.” The acknowledgment came in a court filing submitted this week in Trump's lawsuit against the bank and its leader, Jamie Dimon. “In February 2021, JPMorgan informed Plaintiffs that certain accounts maintained with JPMorgan’s CB and PB would be closed,” JPMorgan's former chief administrative officer Dan Wilkening wrote in the court filing. Feb 21, 2026 - $JPM
BofA Lowers its Price Target on KKR & Co. Inc. (KKR) to $160 but Maintained a Buy Rating
KKR & Co. Inc. (NYSE:KKR) is among the 10 Best Consensus Buy-Rated Stocks to Invest in. On February 9, 2026, BofA lowered its price target on KKR & Co. Inc. (NYSE:KKR) to $160 from $164 previously but still maintained a Buy rating, revising EPS estimates following fourth-quarter results across its brokers, asset managers, and exchanges […] Feb 21, 2026 - $KKR
EVgo (EVGO) Builds Momentum in Clean Transportation Solutions
EVgo Inc. (NASDAQ:EVGO) is one of the best alternative energy stocks to invest in according to analysts. On January 27, EVgo Inc. (NASDAQ:EVGO) said it plans to roll out North American Charging Standard, or NACS, connectors across its network. Also known as SAE J3400, the connector type was originally developed by Tesla and has since […] Feb 21, 2026 - $KR
Jefferies Raises its Price Target on Krystal Biotech, Inc. (KRYS) to $371 and Maintains a Buy Rating
Krystal Biotech, Inc. (NASDAQ:KRYS) is among the 11 Best All-Time High Stocks to Buy According to Wall Street. On February 17, 2026, Jefferies analyst Roger Song raised the price target on Krystal Biotech, Inc. (NASDAQ:KRYS) to $371 from $310 and maintained a Buy rating. Roger Song noted another strong quarter and full year, with Vyjuvek […] Feb 21, 2026 - $KRYS
We use cookies and similar technologies to collect and process data such as browsing activity or unique identifiers.
Selecting "Allow All" to help us understand site usage and improve the platform.
Choosing "Essential Cookies Only" enables only the cookies necessary for core site functions, such as staying logged in.
For more information, please see our Privacy Policy.
Continue with Google
Continue with Facebook
Continue with Microsoft
Continue with Apple